Clinical Trials for IgA Nephropathy

Find clinical trials for iga nephropathy. Discover research opportunities and treatment options in your area.

28 Active Trials Found

Showing 28 trials on this page

Page 1 of 2

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

NCT ID: NCT06676384

This clinical trial is investigating whether adding certain approved medications to the standard treatment can improve kidney function in adults with a specific kidney disease called IgA Nephropath...

Recruiting

Phase: PHASE4 Type: interventional Locations: Mumbai, Maharashtra, India, Lucknow, Uttar Pradesh, India +10 more

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

NCT ID: NCT06712407

This clinical trial is studying the effectiveness and safety of continuing TARPEYO® treatment for adults with a kidney condition called primary IgA nephropathy (IgAN) beyond the initial 9 months of...

Recruiting

Phase: PHASE4 Type: interventional Locations: New York, New York, United States, Augusta, Georgia, United States +17 more

Study of BHV-1400 in IgA Nephropathy

NCT ID: NCT07054684

This clinical trial is studying a new treatment called BHV-1400 for people with IgA Nephropathy, a kidney condition where a protein called IgA builds up and causes damage. The main goal of this ear...

Not yet recruiting

Phase: PHASE1 Type: interventional

Nefecon and Ambrisentan in IgA Nephropathy

NCT ID: NCT07030894

This clinical trial is studying a new treatment approach for people with IgA nephropathy, a kidney disease that can lead to chronic kidney problems and protein in the urine. The trial will look at ...

Not yet recruiting

Phase: PHASE4 Type: interventional

A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy Subjects

NCT ID: NCT07035665

This clinical trial is studying how food affects the way the body absorbs and processes a new medicine called HRS-5965, which is taken as a capsule. The goal is to understand if eating before takin...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study

NCT ID: NCT06350630

The QUIgAN study is a clinical trial that is investigating the effects of a medication called hydroxychloroquine on a kidney condition known as IgA nephropathy, or Berger disease. This condition ca...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Lyon, , France, Paris, , France +5 more

A Study of Zigakibart in Adults With IgA Nephropathy

NCT ID: NCT05852938

This clinical trial is studying a new treatment called BION-1301 for adults with IgA Nephropathy, a kidney condition where the immune system mistakenly deposits a protein called IgA in the kidneys,...

Recruiting

Phase: PHASE3 Type: interventional Locations: San Francisco, California, United States, Penrith, New South Wales, Australia +239 more

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

NCT ID: NCT07010250

This clinical trial is looking at a condition called ANCA associated vasculitis, which affects the kidneys, and aims to understand how changes in kidney metabolism might lead to kidney damage. The ...

Not yet recruiting

Type: observational Locations: Paris, , France

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

NCT ID: NCT06740526

This clinical trial is studying the effects of a medication called sibeprenlimab on a kidney condition known as immunoglobulin A nephropathy (IgAN). The goal is to see how this treatment might chan...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Denver, Colorado, United States +4 more

Study of ARO-CFB in Adult Healthy Volunteers and Patients With Complement-Mediated Kidney Disease

NCT ID: NCT06209177

This clinical trial, called AROCFB-1001, is investigating a new treatment named ARO-CFB for adults with a kidney disease called IgA Nephropathy (IgAN) and for healthy volunteers. The main goals are...

Recruiting

Phase: PHASE1 Type: interventional Locations: Auckland, , New Zealand

Correlation of Microbiome and Metabonomics With IgA Nephropathy

NCT ID: NCT05190848

This clinical trial is studying a condition called IgA Nephropathy (IgAN), which is a type of kidney disease that is common in China. Researchers want to understand how the bacteria in our mouths a...

Recruiting

Type: observational Locations: Guangzhou, Guangdong, China, Guangzhou, Guangdong, China +3 more

Study of CM313 in Subject With IgA Nephropathy

NCT ID: NCT06830395

This clinical trial is studying a new treatment called CM313 for people with a kidney condition known as IgA nephropathy. The goal of the study is to find out if CM313 is safe and effective in help...

Not yet recruiting

Phase: PHASE2 Type: interventional

TESTING -ON Post-Trial ObservatioNal Cohort Study

NCT ID: NCT05434325

The TESTING -ON study is looking at the long-term effects of a medication called oral methylprednisolone on patients with certain kidney diseases, including IgA Nephropathy and End Stage Kidney Dis...

Recruiting

Type: observational Locations: Adelaide, South Australia, Australia, Toronto, Ontario, Canada +64 more

A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases

NCT ID: NCT06774664

This clinical trial is studying a new medication called SCTC21C to see how safe and effective it is for people with IgA nephropathy, a kidney condition caused by an issue with the immune system. Th...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China, Guangzhou, , China +19 more

A Study of Probiotics in IgA Nephropathy

NCT ID: NCT06767592

This clinical trial is looking at the effects of probiotics on patients with IgA nephropathy (IgAN), a kidney condition that can lead to kidney damage and possibly failure. Researchers believe that...

Recruiting

Phase: NA Type: interventional Locations: Leicester, Leicestershire, United Kingdom

IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients

NCT ID: NCT06690359

The IM19 clinical trial is investigating a new treatment called CAR-T cell therapy for patients with two specific kidney conditions: IgA nephropathy and primary membranous nephropathy. This trial a...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional

Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy

NCT ID: NCT05775042

This clinical trial is studying a new treatment called CM338 for people with Immunoglobulin A (IgA) nephropathy, a kidney condition that can affect how well your kidneys work. The goal of the study...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China, Beijing, Beijing, China

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects

NCT ID: NCT05942625

This clinical trial, called a "first in human" study, is investigating a new treatment called HS-10390 to see if it is safe and how it works in the body. The study focuses on healthy adults aged 18...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nanjing, Jiangsu, China

Effect of Finerenone in IgA Nephropathy

NCT ID: NCT06580288

This clinical trial is studying a medication called Finerenone to see if it can help patients with a kidney condition known as IgA nephropathy. The goal is to find out if Finerenone can reduce prot...

Not yet recruiting

Phase: PHASE3 Type: interventional

Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)

NCT ID: NCT06454110

This clinical trial is studying a new treatment called NM8074 for patients with IgA Nephropathy, a kidney condition that can cause problems with protein in the urine. The goal of the study is to se...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions